Standard Biotools (LAB) Net Cash Flow (QoQ) (2010 - 2026)
Standard Biotools (LAB) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 186.78 Bn | 179.48 Bn | 6.27 Bn |
| 2 | Stryker | 131.95 Bn | 129.07 Bn | 3.81 Bn |
| 3 | Medtronic | 111.27 Bn | 102.05 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.63 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.23 Bn | 26.94 Bn | 1.98 Bn |
| 7 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 28.19 Bn | 27.62 Bn | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn |
| 10 | Standard Biotools | 305.20 Mn | -149.97 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,777.74% |
| Dec 31, 2025 | 70.31% |
| Sep 30, 2025 | -517.49% |
| Jun 30, 2025 | 144.22% |
| Mar 31, 2025 | 63.35% |
| Dec 31, 2024 | 27.06% |
| Sep 30, 2024 | -242.49% |
| Jun 30, 2024 | -107.27% |
| Mar 31, 2024 | 936.97% |
| Dec 31, 2023 | 54.91% |
| Sep 30, 2023 | -317.68% |
| Jun 30, 2023 | -10.58% |
| Mar 31, 2023 | 54.42% |
| Dec 31, 2022 | 249.81% |
| Sep 30, 2022 | -131.03% |
| Jun 30, 2022 | 2,666.23% |
| Sep 30, 2021 | -3.65% |
| Jun 30, 2021 | -100.63% |
| Mar 31, 2021 | -357.19% |
| Dec 31, 2020 | -114.20% |